ChipCare Corporation
$42,900.00 CAD
≈ 7 months of average Canadian pay
- Department
- National Research Council Canada
- Recipient country
- Canada
- Fiscal year
- 2020-2021
- Agreement period
- October 1, 2020 – May 31, 2021
- Reference
- nrc-cnrc:172-2020-2021-Q3-957327
Published purpose
Growing evidence suggests that T-cell immunity against the virus is long-lasting and protective against re-infection. ChipCare is investigating a potential assay that will help identify individuals who have been exposed to a SARS corona virus in the past and may therefore have immunity to SARS-CoV2. The purpose of this project is to establish the clinical need, research appropriate markers, define the market opportunity and requirements for such an assay and to assess the suitability of such an assay for use in point-of-care settings using ChipCare’s platform.
Community tags
Tags are applied by readers, not by this site. One tag per person per record.
Good value
Local impact
Needs context
Questionable
Success story
Wasteful
View official source record
Imported August 3, 2026 from open.canada.ca Grants & Contributions